Calling for urgent interventions to promote discussions between patients and doctors about the cost of medicines to treat asthma, a new study pointed out that out-of-pocket costs are preventing many people from taking vital asthma medication.
The most commonly prescribed preventer treatments for asthma contain inhaled corticosteroids (ICS) which, if taken regularly, reduce the severity of the disease and the number of asthma-related deaths, said the researchers led by The George Institute for Global Health and the Woolcock Institute of Medical Research at UNSW Sydney.
Also Read: Traffic pollution caused asthma in 350,000 Indian kids in 2015: Lancet study
To reach this conclusion, researchers surveyed 1,400 people with asthma in Australia and found that half of the adults and one-third of the children in the study were either decreasing or skipping doses of asthma medicines to make them last longer.
According to reports, at least one in every 10 asthma patient globally lives in India and the economic costs associated with asthma exceed those of TB and HIV/AIDS combined.
“We know that preventer inhalers can be incredibly effective at controlling symptoms and preventing people from being hospitalised or even from dying of asthma, yet our study has found that out-of-pocket costs are preventing many from accessing medicines which can be life-saving,” said senior research fellow Tracey-Lea Laba of The George Institute.
The study, published in The Journal of Allergy and Clinical Immunology: In Practice, found that young male adults were most likely to under-use asthma treatments.
This was compounded by doctors being largely unaware that out-of-pocket costs were a significant concern for many of their patients, or that some preventers had lower out-of-pocket costs for patients than others.
According to fellow study author Professor Helen Reddel of the Woolcock Institute at UNSW Sydney, asthma is a long-term disease and one where people really need to keep the inflammation under control by taking a preventative medicine and not just relying on short-term symptom relief from a blue inhaler.
“We need doctors to talk to their patients to stress that this Band-Aid approach does not work, and can leave them hospitalised or even worse as a result,” said Reddel.
Pingback: how to promote your youtube video
Pingback: easy1up review profit passport
Pingback: bài heo đất
Pingback: Buy Vyvanse Online
Pingback: marijuana for sale near me
Pingback: english bulldogs for sale in wi
Pingback: keluaran hk
Pingback: Eddie Frenay
Pingback: airport taxi cheltenham to heathrow
Pingback: fake watches
Pingback: winstrol kalpa pharma
Pingback: cvv shop
Pingback: 메이저놀이터
Pingback: cbd for anxiety
Pingback: DevOps
Pingback: Pittsfield Town Towing
Pingback: My Website
Pingback: euroclub
Pingback: replicas montblanc sport watch
Pingback: best cvv shop
Pingback: https://upholsteryclean.info
Pingback: cheap cvv shop online
Pingback: DevOps Development Services
Pingback: Capacitacion De Modelos Webcam
Pingback: Sex Live Noir Marseillaise
Pingback: Where to buy magic mushroom in Denver
Pingback: nova88
Pingback: yellow cap mushroom
Pingback: sbobet
Pingback: ยืมเงินด่วน
Pingback: ยืมเงินด่วน
Pingback: how to generate passive income
Pingback: pour apprendre plus